comparemela.com

Piotr Czubkowski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Odevixibat Significantly Benefits Pediatric PFIC Regardless of Patient Subtype

Data from the phase 3 PEDFIC trial program show the IBAT inhibitor benefits bile acid levels as well as itch and sleep issues among children with varying types of PFIC.

vimarsana © 2020. All Rights Reserved.